Skip to main content

Table 4 Average costs for each phase of sarcoma management by group (in €, 2009)

From: Clinicians' adherence versus non adherence to practice guidelines in the management of patients with sarcoma: a cost-effectiveness assessment in two European regions

Phases of treatment

All patients

CPG (+)

CPG (-)

p

Diagnosis

overall

3,701 (7420)

4,536 (8,908)

2,728 (5,095)

0.07

 

hospitalization

3,275 (7,376)

4,097 (8,791)

2,317 (4,701)

0.07

 

imaging

259 (198)

274 (210)

241 (182)

0.21

 

biopsy

93 (57)

88 (45)

99 (69)

0.15

 

consultation

74 (96)

77 (88)

71 (105)

0.64

Surgery

overall

8,170 (7,364)

7,397 (6,034)

9,075 (8,639)

0.09

 

hospitalization

7,927 (7,101)

7,163 (5,773)

8,821 (8,363)

0.09

 

imaging

95 (163)

108 (179)

80 (141)

0.21

 

transfusion

148 (384)

126 (384)

174 (386)

0.36

Chemo-therapy

overall

6,107 (11,988)

5,164 (11,197)

7,207 (13,123)

0.22

 

hospitalization

3,913 (8,568)

2,938 (7,176)

5,050 (9,905)

0.07

 

consultation

59 (405)

81 (545)

35 (98)

0.39

 

transfusion

56 (223)

53 (228)

60 (220)

0.20

 

drugs

1,956 (5,171)

1,982 (5,964)

1,925 (4,115)

0.94

 

imaging

123 (279)

110 (277)

137 (284)

0.48

Radio-therapy

overall

2,270 (5,850)

2,078 (5,599)

2,493 (6,173)

0.60

 

hospitalization

1,544 (5,223)

1,449 (4,867)

1,656 (5,658)

0.77

 

sessions

726 (1,266)

629 (1,269)

837 (1,262)

0.23

Initial treatment

20,248 (18,474)

19,175 (17,555)

21,502 (19,778)

0.36

Follow Up

5,048 (11,760)

4,396 (12,343)

5,811 (11,116)

0.38

Overall management

25,296 (22,919)

23,571 (21,913)

27,313 (24,403)

0.23